To review or not to review?

Few and far between are the public companies that shun coverage by sell-side analysts. In fact, this coverage is so highly valued that IROs spend significant time cultivating relationships with analysts in the hope they will initiate and maintain coverage of their companies. Why then do securities lawyers advise extreme care when dealing with analysts, especially when the issue of reviewing and commenting on analyst reports arises? The answer lies in the fact that too much involvement in the